Reporting parties 2 facts
Subject security 3 facts
Symbol
LXEO
Shares outstanding
32,906,556 shares
Ownership signal 2 facts
SEC evidence 4 facts
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 09:00:03 UTC
Event date
31 Dec 2024
SEC filing
View on sec.gov

Key filing fact

Omega Fund VI, L.P. disclosed 3.6% ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO) on 31 Dec 2024.

Key facts

  • Omega Fund VI, L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO).
  • Disclosed ownership: 3.6%.
  • Date of event: 31 Dec 2024.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 09:00.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (6)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Omega Fund VI, L.P. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director of General Partner of General Partner
Omega Fund VI GP, L.P. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director of General Partner
Omega Fund VI GP Manager, Ltd. 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Director
Claudio Nessi 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Attorney-in-Fact
Otello Stampacchia 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia
Francesco Draetta 3.6% 1,184,636 0 1,184,636 /s/ Otello Stampacchia Otello Stampacchia, Attorney-in-Fact
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .